BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu X, Wu Z, Lian J, Hu CH, Huang XF, Deng C. Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in rats. Sci Rep 2017;7:2762. [PMID: 28584269 DOI: 10.1038/s41598-017-02884-w] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Harjaningsih W, Ayunirrahmah L, Putri NJV. The therapeutic outcomes and adverse drug reactions study of Clozapine on Schizophrenia inpatients in the Grhasia psychiatric hospital Yogyakarta, Indonesia. PE. [DOI: 10.46542/pe.2021.212.287295] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Okada M, Fukuyama K, Shiroyama T, Murata M. A Working Hypothesis Regarding Identical Pathomechanisms between Clinical Efficacy and Adverse Reaction of Clozapine via the Activation of Connexin43. Int J Mol Sci 2020;21:E7019. [PMID: 32987640 DOI: 10.3390/ijms21197019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
3 Ren L, Sun D, Zhou X, Yang Y, Huang X, Li Y, Wang C, Li Y. Chronic treatment with the modified Longdan Xiegan Tang attenuates olanzapine-induced fatty liver in rats by regulating hepatic de novo lipogenesis and fatty acid beta-oxidation-associated gene expression mediated by SREBP-1c, PPAR-alpha and AMPK-alpha. J Ethnopharmacol 2019;232:176-87. [PMID: 30590197 DOI: 10.1016/j.jep.2018.12.034] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
4 Liu X, Feng X, Deng C, Liu L, Zeng Y, Hu CH. Brown adipose tissue activity is modulated in olanzapine-treated young rats by simvastatin. BMC Pharmacol Toxicol 2020;21:48. [PMID: 32605639 DOI: 10.1186/s40360-020-00427-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Gunawan S, Aulia A, Soetikno V. Development of rat metabolic syndrome models: A review. Vet World 2021;14:1774-83. [PMID: 34475697 DOI: 10.14202/vetworld.2021.1774-1783] [Reference Citation Analysis]
6 Su Y, Liu X, Lian J, Deng C. Epigenetic histone modulations of PPARγ and related pathways contribute to olanzapine-induced metabolic disorders. Pharmacological Research 2020;155:104703. [DOI: 10.1016/j.phrs.2020.104703] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
7 Cao T, Chen Q, Zhang B, Wu X, Zeng C, Zhang S, Cai H. Clozapine Induced Disturbances in Hepatic Glucose Metabolism: The Potential Role of PGRMC1 Signaling. Front Endocrinol (Lausanne) 2021;12:727371. [PMID: 34970218 DOI: 10.3389/fendo.2021.727371] [Reference Citation Analysis]
8 Zhao T, Zhang K, Zhang Y, Yang Y, Ning X, Hu Y, Li X, Zhang Y, Xia L, Ren Z, Liu H. Do proinflammatory cytokines play a role in clozapine-associated glycometabolism disorders? Psychopharmacology (Berl) 2021;238:1979-90. [PMID: 33774704 DOI: 10.1007/s00213-021-05824-9] [Reference Citation Analysis]
9 Aringhieri S, Carli M, Kolachalam S, Verdesca V, Cini E, Rossi M, McCormick PJ, Corsini GU, Maggio R, Scarselli M. Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences. Pharmacol Ther 2018;192:20-41. [PMID: 29953902 DOI: 10.1016/j.pharmthera.2018.06.012] [Cited by in Crossref: 61] [Cited by in F6Publishing: 50] [Article Influence: 15.3] [Reference Citation Analysis]
10 Liu XM, Zhao XM, Deng C, Zeng YP, Hu CH. Simvastatin improves olanzapine-induced dyslipidemia in rats through inhibiting hepatic mTOR signaling pathway. Acta Pharmacol Sin 2019;40:1049-57. [PMID: 30728467 DOI: 10.1038/s41401-019-0212-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
11 Zhuo C, Xu Y, Hou W, Chen J, Li Q, Liu Z, Dou G, Sun Y, Li R, Ma X, Tian H, Zhou C. Mechanistic/mammalian target of rapamycin and side effects of antipsychotics: insights into mechanisms and implications for therapy. Transl Psychiatry 2022;12:13. [PMID: 35013125 DOI: 10.1038/s41398-021-01778-w] [Reference Citation Analysis]
12 Vantaggiato C, Panzeri E, Citterio A, Orso G, Pozzi M. Antipsychotics Promote Metabolic Disorders Disrupting Cellular Lipid Metabolism and Trafficking. Trends Endocrinol Metab 2019;30:189-210. [PMID: 30718115 DOI: 10.1016/j.tem.2019.01.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
13 Grajales D, Ferreira V, Valverde ÁM. Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain. Cells 2019;8:E1336. [PMID: 31671770 DOI: 10.3390/cells8111336] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 8.7] [Reference Citation Analysis]
14 Yang CP, Wang YY, Lin SY, Hong YJ, Liao KY, Hsieh SK, Pan PH, Chen CJ, Chen WY. Olanzapine Induced Dysmetabolic Changes Involving Tissue Chromium Mobilization in Female Rats. Int J Mol Sci 2019;20:E640. [PMID: 30717287 DOI: 10.3390/ijms20030640] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Chen J, Huang XF, Shao R, Chen C, Deng C. Molecular Mechanisms of Antipsychotic Drug-Induced Diabetes. Front Neurosci 2017;11:643. [PMID: 29209160 DOI: 10.3389/fnins.2017.00643] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 7.4] [Reference Citation Analysis]
16 Mukherjee S, Skrede S, Milbank E, Andriantsitohaina R, López M, Fernø J. Understanding the Effects of Antipsychotics on Appetite Control. Front Nutr 2021;8:815456. [PMID: 35047549 DOI: 10.3389/fnut.2021.815456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Del Campo A, Bustos C, Mascayano C, Acuña-Castillo C, Troncoso R, Rojo LE. Metabolic Syndrome and Antipsychotics: The Role of Mitochondrial Fission/Fusion Imbalance. Front Endocrinol (Lausanne) 2018;9:144. [PMID: 29740394 DOI: 10.3389/fendo.2018.00144] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
18 Lian J, Deng C. The dosage-dependent effects of cevimeline in preventing olanzapine-induced metabolic side-effects in female rats. Pharmacol Biochem Behav 2020;191:172878. [PMID: 32112786 DOI: 10.1016/j.pbb.2020.172878] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Zhuo C, Xu Y, Wang H, Zhou C, Liu J, Yu X, Shao H, Tian H, Fang T, Li Q, Chen J, Xu S, Ma X, Yang W, Yao C, Li B, Yang A, Chen Y, Huang G, Lin C. Clozapine induces metformin-resistant prediabetes/diabetes that is associated with poor clinical efficacy in patients with early treatment-resistant schizophrenia. J Affect Disord 2021;295:163-72. [PMID: 34464878 DOI: 10.1016/j.jad.2021.08.023] [Reference Citation Analysis]
20 Li N, Cao T, Wu X, Tang M, Xiang D, Cai H. Progress in Genetic Polymorphisms Related to Lipid Disturbances Induced by Atypical Antipsychotic Drugs. Front Pharmacol 2019;10:1669. [PMID: 32116676 DOI: 10.3389/fphar.2019.01669] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
21 Galal A, El-Bakly WM, El-Kilany SS, Ali AA, El-Demerdash E. Fenofibrate ameliorates olanzapine's side effects without altering its central effect: emphasis on FGF-21-adiponectin axis. Behav Pharmacol 2021;32:615-29. [PMID: 34637209 DOI: 10.1097/FBP.0000000000000656] [Reference Citation Analysis]
22 He M, Yao J, Zhang Z, Zhang Y, Chen R, Gu Z, Huang X, Deng C, Zhou R, Fan J, Zhang B, Xie Y, Gao G, Sun T. Gold nanoclusters eliminate obesity induced by antipsychotics. Sci Rep 2022;12:5502. [PMID: 35365730 DOI: 10.1038/s41598-022-09541-x] [Reference Citation Analysis]
23 Ashraf GM, Alghamdi BS, Alshehri FS, Alam MZ, Tayeb HO, Tarazi FI. Empagliflozin Effectively Attenuates Olanzapine-Induced Body Weight Gain in Female Wistar Rats. Front Pharmacol 2021;12:578716. [PMID: 33953666 DOI: 10.3389/fphar.2021.578716] [Reference Citation Analysis]
24 Bába LI, Kolcsár M, Kun IZ, Ulakcsai Z, Bagaméry F, Szökő É, Tábi T, Gáll Z. Effects of Cariprazine, Aripiprazole, and Olanzapine on Mouse Fibroblast Culture: Changes in Adiponectin Contents in Supernatants, Triglyceride Accumulation, and Peroxisome Proliferator-Activated Receptor-γ Expression. Medicina (Kaunas) 2019;55:E160. [PMID: 31108997 DOI: 10.3390/medicina55050160] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]